0001193125-26-048855
SEC filingMercer International Inc. (MERC) reported a substantial net loss of $497.9M for FY 2025, ending December 31, 2025, driven by significant impairments and high operating costs amid $1.87B in revenues. Operating loss reached $397.7M, primarily due to $215.7M in impairments of long-lived assets, elevated cost of sales excluding depreciation at $1.78B, cost of sales depreciation and amortization of $159.8M, and selling, general and administrative expenses of $114.4M. Interest expense contributed $114.8M to other expenses, resulting in a pre-tax loss of $511.2M, partially offset by a $13.3M income tax recovery. Basic and diluted loss per share was $7. Despite the net loss, operating cash flow was positive at $8.6M, supported by non-cash adjustments including $215.7M impairments and $160.0M depreciation. Balance sheet shows total assets of $2.04B, with property, plant and equipment at $1.12B, long-term debt of $1.61B, and shareholders' equity of $68.1M. Cash and equivalents stood at $186.8M, with net cash increase of $1.9M. No dividends were declared. High leverage and asset impairments signal challenges, though modest operating cash generation provides some liquidity buffer.
Mercer International Inc. reported revenues of $1.87B for the fiscal year ended December 31, 2025, but incurred a significant operating loss of $397.7M and net loss of $497.9M. Key drivers included cost of sales excluding depreciation and amortization at $1.78B, cost of sales depreciation and amortization of $159.8M, selling, general and administrative expenses of $114.4M, and impairments of long-lived assets totaling $215.7M. Interest expense was $114.8M, leading to total other expenses net of $113.5M and loss before income taxes of $511.2M. An income tax recovery of $13.3M reduced the net loss. Basic and diluted net loss per common share was $7, with no dividends declared per common share. Total assets stood at $2.04B, total liabilities at $1.97B, and shareholders' equity at $68.1M. No prior year figures are provided in the filing for direct comparison.
Revenues totaled $1.87B for FY 2025. No segment breakdown, geographic mix, or specific growth drivers are disclosed in the provided XBRL data or document content. Cost of sales components dominate expenses, with $1.78B excluding depreciation and $159.8M in depreciation and amortization related to cost of sales.
Operating loss of $397.7M on $1.87B revenues reflects severe pressure from impairments ($215.7M) and high cost structure. No gross profit figure is explicitly stated, but cost of sales elements total approximately $1.94B before other operating expenses. Selling, general and administrative expenses at $114.4M further eroded profitability. No prior period margins available for trend analysis. The $215.7M impairments of long-lived assets and $54.4M inventory impairment in cash flow adjustments highlight significant non-cash charges impacting profitability.
Net cash from operating activities was $8.6M, despite $497.9M net loss, bolstered by $160.0M depreciation, $215.7M asset impairments, and $54.4M inventory impairment, offset by working capital changes including -$52.6M in accounts receivable. Investing activities used $81.3M, driven by $88.6M property, plant and equipment purchases and $82.1M acquisition. Financing provided $79.8M, mainly from $102.9M net revolving credit facilities, minus $10.0M dividends and $13.2M finance lease payments. Balance sheet shows $865.8M current assets (cash $186.8M, receivables $298.9M, inventories $359.4M), $1.12B net PP&E, $1.61B long-term debt, and $283.6M current liabilities. Liquidity supported by $186.8M cash; leverage high with debt exceeding equity 23x.
No management guidance, strategic priorities, or specific risk factors are disclosed in the provided filing content. Commitments and contingencies referenced in Note 21, but no details provided.